Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: A prospective observational study

International Journal of Geriatric Psychiatry

Volumn 29, Issue 3, 2014, Pages 253-262

  Hatta, Kotaro ^a   Kishi, Yasuhiro ^b   Wada, Ken ^c   Odawara, Toshinari ^d   Takeuchi, Takashi ^e   Shiganami, Takafumi ^f   Tsuchida, Kazuo ^g   Oshima, Yoshio ^h   Uchimura, Naohisa ⁱ   Akaho, Rie ^j   Watanabe, Akira ^k   Taira, Toshihiro ^l   Nishimura, Katsuji ^m   Hashimoto, Naoko ⁿ   Usui, Chie ^a   Nakamura, Hiroyuki ^o  

^a JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^c HIROSHIMA CITY HOSPITAL   (Japan)

^d YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

^g KURASHIKI CENTRAL HOSPITAL   (Japan)

^h NATIONAL CANCER CENTER HOSPITAL   (Japan)

ⁱ KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^k KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^l Fukuyama City Hospital   (Japan)

^m TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

ⁿ TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^o KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

more..

Author keywords

adverse event; antipsychotic; aripiprazole; aspiration pneumonia; delirium; haloperidol; olanzapine; perospirone; quetiapine; risperidone

Indexed keywords

ADVERSE EVENT; ANTIPSYCHOTIC; ARIPIPRAZOLE; ASPIRATION PNEUMONIA; DELIRIUM; HALOPERIDOL; OLANZAPINE; PEROSPIRONE; QUETIAPINE; RISPERIDONE;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; DELIRIUM; FEMALE; HOSPITALS, GENERAL; HUMANS; MALE; PNEUMONIA, ASPIRATION; PROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM; WOUNDS AND INJURIES;

EID: 84893931911     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3999     Document Type: Article

References (21)

1. American Psychiatric Association. 1999. Practice guideline for the treatment of patients with delirium. Am J Psychiatry 156 (5 Suppl): 1-20.
2. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorder, Text Revision. 4th edition. American Psychiatric Press: Washington, DC.
3. Devlin JW, Roberts RJ, Fong JJ, et al., 2010. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 38: 419-427.
4. Elie M, Boss K, Cole MG, et al., 2009. A retrospective, exploratory, secondary analysis of the association between antipsychotic use and mortality in elderly patients with delirium. Int Psychogeriatr 21: 588-592.
5. Gardner DM, Murphy AL, O'Donnell H, et al., 2010. International consensus study of antipsychotic dosing. Am J Psychiatry 167: 686-693.
6. Guy W,. 1976. ECDEU assessment manual for psychopharmacology. US Dept of Health, Education, and Welfare: Bethesda.
7. Huybrechts KF, Gerhard T, Crystal S, et al., 2012. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ 344: e977.
8. Inada T., 1996. Evaluation and Diagnosis of Drug-induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to its Usage. Seiwa Shoten Publishers: Tokyo.
9. Knol W, van Marum RJ, Jansen PA, et al., 2008. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 56: 661-666.
10. Lacasse H, Perreault MM, Williamson DR,. 2006. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother 40: 1966-1973.
11. Lonergan E, Britton AM, Luxenberg J, et al., 2007. Antipsychotics for delirium. Cochrane Database Syst Rev 2: CD005594.
12. Ma N, Liu WY, Li HD, et al., 2007. Determination of perospirone by liquid chromatography/electrospray mass spectrometry: application to a pharmacokinetic study in healthy Chinese volunteers. J Chromatogr B Analyt Technol Biomed Life Sci 847: 210-216
13. Marder SR, McQuade RD, Stock E, et al., 2003. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res 61: 123-136.
14. Meagher D, Moran M, Raju B, et al., 2008. A new data-based motor subtype schema for delirium. J Neuropsychiatry Clin Neurosci 20: 185-193.
15. Menza MA, Murray GB, Holmes VF, et al., 1987. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 48: 278-280.
16. Michaud L, Büla C, Berney A, et al. 2007. Delirium: guidelines for general hospitals. J Psychosom Res 62: 371-383.
17. Schneider LS, Dagerman KS, Insel P,. 2005. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294: 1934-1943.
18. Tahir TA, Eeles E, Karapareddy V, et al., 2010. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 69: 1 485-490.
19. Trzepacz PT,. 1999. The delirium rating scale. Its use in consultation-liaison research. Psychosomatics 40: 193-204.
20. US Food and Drug Administration. 2005. FDA Public Health Advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. [http://www.fda.gov/cder/drug/advisory/antipsychotics.htm]
21. Wang PS, Schneeweiss S, Avorn J, et al., 2005. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 353: 2335-2341.